Vivus Inc | search
Click here to view Vivus Inc news from 60+ newspapers.
Bookmark or Share- Vivus | VVUS Stock Price, Company Overview & News - ForbesIn trading on Wednesday, shares of Vivus, Inc. (NASD: VVUS) crossed above their 200 day moving average of $14.23, changing hands as high as $14.26 per share.
- VIVUS: Advancing Innovative Clinical TherapiesWith demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.
- VIVUS Receives Court Approval of Joint Chapter 11 Plan of ReorganizationCAMPBELL, Calif., Dec. 11, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (the “Company”), a biopharmaceutical company, today announced that it has received approval from the United States Bankruptcy...
- Vivus - WikipediaVivus (OTC Pink: VVUSQ) is a small pharmaceutical company headquartered in Campbell, California, working in obesity, sleep, and sexual health. Vivus is developing an erectile dysfunction drug, Avanafil, that has completed Phase 3 clinical trials. [1]
- Our history - VivusLearn about the evolution of VIVUS and the expansion of our business globally. Swipe, click through or select a year to navigate our interactive timeline. VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases.
More
